Market Place
Sourcing Support
Intrommune Toothpaste For Peanut Allergy Shows Safety Win
28 May 2025 //
GLOBENEWSWIRE
Intrommune Therapeutics Publishes OMEGA Study in Allergy Journal
19 Feb 2025 //
GLOBENEWSWIRE
Intrommune Presents Oral Mucosal Immunotherapy Updates
21 May 2024 //
GLOBENEWSWIRE
Intrommune Therapeutics Strengthens Board of Directors
12 Mar 2024 //
GLOBENEWSWIRE
Intrommune Presents Data Introducing a New Form of Food Allergy Treatment
22 Feb 2024 //
GLOBENEWSWIRE
Intrommune Therapeutics To Present A New Form Of Allergy Treatment
06 Feb 2024 //
GLOBENEWSWIRE
Inimmune Corporation and Intrommune Therapeutics announce a collaboration
08 Jan 2024 //
GLOBENEWSWIRE
Intrommune Therapeutics Presents Positive Results of Phase 1 of INT301
09 Nov 2023 //
GLOBENEWSWIRE
Intrommune Completes Last Patient Last Visit in Phase 1 Study for Peanut Allergy
25 Jul 2023 //
GLOBENEWSWIRE
Intrommune Completes Enrollment in the Phase 1 OMEGA Study for Peanut Allergy
26 Oct 2022 //
GLOBENEWSWIRE
Intrommune Expands and Strengthens Senior Leadership Team
28 Sep 2022 //
GLOBENEWSWIRE
Intrommune Announces Expanded Scope of PI OMEGA Study in Peanut Allergy
22 Jun 2022 //
GLOBENEWSWIRE
Intrommune Therapeutics Names Nandini Murthy as Head of Regulatory
01 Jun 2022 //
GLOBENEWSWIRE
Intrommune previews Phase II trial design for peanut allergy toothpaste
11 May 2022 //
CLINICALTRIALSARENA
Intrommune Reports Positive Update from Ongoing Phase 1 Study in Peanut Allergy
08 Feb 2022 //
GLOBENEWSWIRE
Intrommune Therapeutics Names Sergi X. Trilla its Director, Corporate Strategy
21 Dec 2021 //
GLOBENEWSWIRE
Intrommune Therapeutics Announces Arrival of Stuart Loesch as New CCO
08 Sep 2021 //
GLOBENEWSWIRE
Intrommune Therapeutics Launches #PeanutAllergyStrong
24 Aug 2021 //
GLOBENEWSWIRE
Intrommune MD, MBA to its Scientific and Business Advisory Boards
28 Jul 2021 //
GLOBENEWSWIRE
Intrommune Therapeutics Presents at Next Generation Food Allergy Drug Summit
22 Jul 2021 //
GLOBENEWSWIRE
Intrommune Therapeutics Presents at Next Generation Food Allergy Drug Summit
22 Jul 2021 //
GLOBENEWSWIRE
Intrommune Therapeutics to Present at BIO Digital 2021
17 Jun 2021 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.